Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
18.61
-0.05 (-0.27%)
Aug 31, 2026, 3:00 PM CST
SHA:600079 Revenue
Humanwell Healthcare (Group) had revenue of 5.96B CNY in the quarter ending June 30, 2026, with 0.56% growth. This brings the company's revenue in the last twelve months to 23.96B, down -2.76% year-over-year. In the year 2025, Humanwell Healthcare (Group) had annual revenue of 23.96B, down -5.79%.
Revenue (ttm)
23.96B
Revenue Growth
-2.76%
P/S Ratio
1.27
Revenue / Employee
1.40M
Employees
17,153
Market Cap
30.46B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.96B | -1.47B | -5.79% |
| Dec 31, 2024 | 25.44B | 910.74M | 3.71% |
| Dec 31, 2023 | 24.52B | 2.19B | 9.79% |
| Dec 31, 2022 | 22.34B | 1.79B | 8.71% |
| Dec 31, 2021 | 20.55B | -131.18M | -0.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Resources Sanjiu Medical & Pharmaceutical | 31.81B |
| Beijing Tongrentang | 16.64B |
| Changchun High-Tech Industry (Group) | 11.02B |
| Apeloa Pharmaceutical Co.,Ltd | 9.16B |
| Zhejiang Huahai Pharmaceutical | 8.98B |
| Shijiazhuang Yiling Pharmaceutical | 7.87B |
| Dong-E-E-Jiao | 6.80B |
| Hubei Jumpcan Pharmaceutical | 5.80B |
Humanwell Healthcare (Group) News
- 6 days ago - Humanwell Healthcare (Group) Quarterly report: H1 2026 - Filings
- 4 months ago - Humanwell Healthcare (Group) Quarterly report: Q1 2026 - Filings
- 5 months ago - Humanwell Healthcare (Group) Annual report: H2 2025 - Filings
- 10 months ago - Humanwell Healthcare (Group) Quarterly report: Q3 2025 - Filings